202 related articles for article (PubMed ID: 26428435)
41. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
[TBL] [Abstract][Full Text] [Related]
42. The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling.
Berning P; Schaefer C; Clemens D; Korsching E; Dirksen U; Potratz J
Cell Commun Signal; 2018 May; 16(1):21. PubMed ID: 29776413
[TBL] [Abstract][Full Text] [Related]
43. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
[TBL] [Abstract][Full Text] [Related]
44. CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment.
Han Y; Wu C; Wang J; Liu N
Tumour Biol; 2017 May; 39(5):1010428317701631. PubMed ID: 28468584
[TBL] [Abstract][Full Text] [Related]
45. Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
Chifu I; Heinze B; Fuss CT; Lang K; Kroiss M; Kircher S; Ronchi CL; Altieri B; Schirbel A; Fassnacht M; Hahner S
Front Endocrinol (Lausanne); 2020; 11():597878. PubMed ID: 33281749
[TBL] [Abstract][Full Text] [Related]
46. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.
San-Miguel T; Pinto S; Navarro L; Callaghan RC; Monteagudo C; López-Ginés C; Cerdá-Nicolás M; Gil-Benso R
Pathol Oncol Res; 2015 Sep; 21(4):1191-9. PubMed ID: 26037167
[TBL] [Abstract][Full Text] [Related]
47. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
48. Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma.
Baumhoer D; Smida J; Zillmer S; Rosemann M; Atkinson MJ; Nelson PJ; Jundt G; von Luettichau I; Nathrath M
Mod Pathol; 2012 Apr; 25(4):522-8. PubMed ID: 22173290
[TBL] [Abstract][Full Text] [Related]
49. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.
Hunger C; Ödemis V; Engele J
Exp Cell Res; 2012 Oct; 318(17):2178-90. PubMed ID: 22766125
[TBL] [Abstract][Full Text] [Related]
50. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.
Sand LG; Berghuis D; Szuhai K; Hogendoorn PC
Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431
[TBL] [Abstract][Full Text] [Related]
51. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
[TBL] [Abstract][Full Text] [Related]
52. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
[TBL] [Abstract][Full Text] [Related]
53. Induction of myogenic differentiation by SDF-1 via CXCR4 and CXCR7 receptors.
Melchionna R; Di Carlo A; De Mori R; Cappuzzello C; Barberi L; Musarò A; Cencioni C; Fujii N; Tamamura H; Crescenzi M; Capogrossi MC; Napolitano M; Germani A
Muscle Nerve; 2010 Jun; 41(6):828-35. PubMed ID: 20151462
[TBL] [Abstract][Full Text] [Related]
54. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
Neve Polimeno M; Ierano C; D'Alterio C; Simona Losito N; Napolitano M; Portella L; Scognamiglio G; Tatangelo F; Maria Trotta A; Curley S; Costantini S; Liuzzi R; Izzo F; Scala S
Cell Mol Immunol; 2015 Jul; 12(4):474-82. PubMed ID: 25363530
[TBL] [Abstract][Full Text] [Related]
55. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas.
Flüh C; Hattermann K; Mehdorn HM; Synowitz M; Held-Feindt J
Int J Oncol; 2016 Apr; 48(4):1408-16. PubMed ID: 26821357
[TBL] [Abstract][Full Text] [Related]
57. Computer-aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma.
Yu X; Lu W; Ng CW; Xu S; Wu Y; Chen S; Gao Y; Zhang Y; Zhang Q; Xu Y; Liu Y; Li S
J Cell Mol Med; 2020 Jul; 24(13):7670-7674. PubMed ID: 32512633
[TBL] [Abstract][Full Text] [Related]
58. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
Phillips RJ; Burdick MD; Lutz M; Belperio JA; Keane MP; Strieter RM
Am J Respir Crit Care Med; 2003 Jun; 167(12):1676-86. PubMed ID: 12626353
[TBL] [Abstract][Full Text] [Related]
59. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
[TBL] [Abstract][Full Text] [Related]
60. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]